These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22878814)

  • 1. Latent structure analysis of the process variables and pharmaceutical responses of an orally disintegrating tablet.
    Hayashi Y; Oshima E; Maeda J; Onuki Y; Obata Y; Takayama K
    Chem Pharm Bull (Tokyo); 2012; 60(11):1419-25. PubMed ID: 22878814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent structure analysis in the pharmaceutical process of tablets prepared by wet granulation.
    Uehara N; Hayashi Y; Mochida H; Otoguro S; Onuki Y; Obata Y; Takayama K
    Drug Dev Ind Pharm; 2016 Jan; 42(1):116-122. PubMed ID: 25997364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
    Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of quality attributes (mechanical strength, disintegration behavior and drug release) of tablets on the basis of characteristics of granules prepared by high shear wet granulation.
    Khan A
    PLoS One; 2021; 16(12):e0261051. PubMed ID: 34882723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-organizing map analysis using multivariate data from theophylline tablets predicted by a thin-plate spline interpolation.
    Yasuda A; Onuki Y; Obata Y; Yamamoto R; Takayama K
    Chem Pharm Bull (Tokyo); 2013; 61(3):304-9. PubMed ID: 23449198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of manufacturing method for rapidly disintegrating oral tablets using the crystalline transition of amorphous sucrose.
    Sugimoto M; Narisawa S; Matsubara K; Yoshino H; Nakano M; Handa T
    Int J Pharm; 2006 Aug; 320(1-2):71-8. PubMed ID: 16750604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
    Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
    Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Loratadine Orally Disintegrating Tablets by Semi-solid Extrusion 3D Printing.
    Yi S; Xie J; Chen L; Xu F
    Curr Drug Deliv; 2023; 20(6):818-829. PubMed ID: 36221886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent structure modeling underlying theophylline tablet formulations using a Bayesian network based on a self-organizing map clustering.
    Yasuda A; Onuki Y; Obata Y; Takayama K
    Drug Dev Ind Pharm; 2015; 41(7):1148-55. PubMed ID: 24994002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
    Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
    Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of process variables on the Drucker-Prager cap model and residual stress distribution of tablets estimated by the finite element method.
    Hayashi Y; Otoguro S; Miura T; Onuki Y; Obata Y; Takayama K
    Chem Pharm Bull (Tokyo); 2014; 62(11):1062-72. PubMed ID: 25109913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
    Vercruysse J; Córdoba Díaz D; Peeters E; Fonteyne M; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Sep; 82(1):205-11. PubMed ID: 22687571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
    Hackl E; Ermolina I
    AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twin-screw granulation and high-shear granulation: The influence of mannitol grade on granule and tablet properties.
    Megarry A; Taylor A; Gholami A; Wikström H; Tajarobi P
    Int J Pharm; 2020 Nov; 590():119890. PubMed ID: 32946976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.